0001236031-17-000022.txt : 20171106
0001236031-17-000022.hdr.sgml : 20171106
20171106130514
ACCESSION NUMBER: 0001236031-17-000022
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171102
FILED AS OF DATE: 20171106
DATE AS OF CHANGE: 20171106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KERSTEN GEERT R
CENTRAL INDEX KEY: 0001236030
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11889
FILM NUMBER: 171178940
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CEL SCI CORP
CENTRAL INDEX KEY: 0000725363
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 840916344
STATE OF INCORPORATION: CO
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 8229 BOONE BLVD .
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
BUSINESS PHONE: 7035069460
MAIL ADDRESS:
STREET 1: 8229 BOONE BLVD.
STREET 2: SUITE 802
CITY: VIENNA
STATE: VA
ZIP: 22182
FORMER COMPANY:
FORMER CONFORMED NAME: INTERLEUKIN 2 INC
DATE OF NAME CHANGE: 19880317
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2017-11-02
0
0000725363
CEL SCI CORP
cvm
0001236030
KERSTEN GEERT R
1
1
0
0
Chief Executive Officer
Series RR Warrants
1.65
2017-11-02
4
A
0
54585
0.01
A
2017-11-02
2022-10-30
Common Stock
54585
1031396
I
Beneficiary
Series RR Warrants
1.65
2017-11-02
4
A
0
73965
0.01
A
2017-11-02
2022-10-30
Common Stock
73965
1105361
D
In consideration for extending the maturity date of the Convertible Notes sold in June and July 2017, the Company issued the note holders that agreed to the extension Series RR warrants.
A trust in which Mr. Kersten holds a beneficial interest participated in the offering in July 2017.
Geert Kersten
2017-11-06